Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"NPM-ALK"”.

  1. Multilevel Deregulation of Survival Mechanisms In Npm-Alk+ T-Cell Lymphoma

    <p>The anaplastic lymphoma kinase (ALK) is a single chain transmembrane receptor tyrosine kinase that belongs to the insulin receptor superfamily. Other members of this superfamily include the insulin receptor (IR), type I insulin-like growth factor receptor (IGF-IR), and the leukocyte tyrosine …

    uthsc Repository record for Multilevel Deregulation of Survival Mechanisms In Npm-Alk+ T-Cell Lymphoma (opens in a new tab)

  2. Searching for the missing T Cell Receptor (TCR) in Anaplastic Large Cell Lymphoma (ALCL): Surplus to requirements or a protagonist in lymphomagenesis?

    … entities: ALCL, Anaplastic Lymphoma Kinase (ALK)+, ALCL ALK- and cutaneous ALCL. In the majority of ALCL, ALK+, ALK is expressed as the result of a chromosomal translocation generating Nucleophosmin 1(NPM)-ALK, which is considered the main driver. ALCL have an unusual immunophenotype; they …

    cambridge Repository record for Searching for the missing T Cell Receptor (TCR) in Anaplastic Large Cell Lymphoma (ALCL): Surplus to requirements or a protagonist in lymphomagenesis? (opens in a new tab)

  3. Novel treatment strategy for ALK-positive Anaplastic Large Cell Lymphoma

    Anaplastic Lymphoma Kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a T-cell non-Hodgkin lymphoma characterised by a chromosomal rearrangement [t(2;5) (p23;q25)] involving the ALK and NPM1 genes on chromosomes 2 and 5 respectively. This translocation generates the NPM-ALK fusion …

    cambridge Repository record for Novel treatment strategy for ALK-positive Anaplastic Large Cell Lymphoma (opens in a new tab)

  4. Investigating the genome of Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphoma

    … hyperactivation of Anaplastic Lymphoma Kinase (ALK) as the consequence of a chromosomal translocation. Patients diagnosed with ALCL are still treated with toxic multi-agent chemotherapy and as many as 25-50% of patients relapse. It is clear that continued adaption of current therapies will …

    cambridge Repository record for Investigating the genome of Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphoma (opens in a new tab)

  5. Studying the Transcriptional and Epigenetic Perturbations of Haematopathologies Expressing NPM1-ALK

    Anaplastic lymphoma kinase (ALK) is a tyrosine kinase involved in the development of the gut and nervous system, initially cloned from cases of T-cell lymphoma. ALK has been frequently implicated in diverse cancers through oncogenic translocations, mutations, chromosomal inversion, or amplification …

    cambridge Repository record for Studying the Transcriptional and Epigenetic Perturbations of Haematopathologies Expressing NPM1-ALK (opens in a new tab)